Long‐term effects of androgen deprivation therapy in prostate cancer patients
Top Cited Papers
- 19 June 2002
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 56 (6) , 779-786
- https://doi.org/10.1046/j.1365-2265.2002.01551.x
Abstract
Background Prostate cancer (PCa) is one of the most common cancers in men and has an increasing incidence. In 1999, 37 000 men died from PCa in the USA. Androgen deprivation therapy (ADT) with GnRH a...Keywords
This publication has 26 references indexed in Scilit:
- Bone Loss in Men with Prostate Cancer Treated with Gonadotropin-Releasing Hormone AgonistsJournal of Clinical Endocrinology & Metabolism, 2001
- BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMAJournal of Urology, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinomaCancer, 1998
- Osteoporosis After Orchiectomy for Prostate CancerJournal of Urology, 1997
- Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadismJournal of Clinical Endocrinology & Metabolism, 1996
- Osteoporosis as a Complication of Orchiectomy in 2 Elderly Men with Prostatic CancerJournal of Urology, 1995
- Decreased bone density in elderly men treated with the gonadotropin- releasing hormone agonist decapeptyl (D-Trp6-GnRH)Journal of Clinical Endocrinology & Metabolism, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Pathogenesis of Vertebral Crush Fractures in MenAge and Ageing, 1992